Chemotherapy alone for localized diffuse large B-cell lymphoma [0.03%]
局部病变更限的弥漫性大B细胞淋巴瘤患者的化疗-alone治疗
Laurie H Sehn
Laurie H Sehn
Approximately 25% to 30% of patients with diffuse large B-cell lymphoma (DLBCL) present with limited-stage disease, typically defined as those with nonbulky (
The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification [0.03%]
世界卫生组织分型的大B细胞淋巴瘤的谱系分析
Madhu P Menon,Stefania Pittaluga,Elaine S Jaffe
Madhu P Menon
Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell lymphomas that are clinically, pathologically, and genetically diverse, in part reflecting the functional diversity of the B-cell system. The focus in recent years has been towar...
Inhibitors of B-cell receptor signaling for patients with B-cell malignancies [0.03%]
B细胞受体信号传导抑制剂可治疗B细胞肿瘤患者
Michael Y Choi,Thomas J Kipps
Michael Y Choi
The B-cell receptor (BCR) complex and its associated protein tyrosine kinases play a critical role in the development, proliferation, and survival of normal or malignant B cells. Regulated activity of the BCR complex promotes the expansion ...
Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease? [0.03%]
小淋巴细胞淋巴瘤与慢性淋巴细胞白血病:同一种疾病吗?
Fabio P S Santos,Susan OBrien
Fabio P S Santos
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world, characterized by peripheral blood B-cell lymphocytosis as well as lymphadenopathy, organomegaly, cytopenias, and systemic symptoms. Chronic lymphocytic leu...
Has single-agent rituximab replaced watch-and-wait for a patient with asymptomatic low-grade follicular lymphoma? [0.03%]
利妥昔单抗单药治疗能否取代观察等待策略用于无症状低级别滤泡淋巴瘤患者?
Lisa Lowry,Kirit M Ardeshna
Lisa Lowry
To date, no overall survival benefit has been proven from the immediate treatment of patients with asymptomatic follicular lymphoma (FL) compared with expectant management. Watchful waiting therefore became the standard of care, with patien...
What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma? [0.03%]
症状性低级别滤泡淋巴瘤患者的首选疗法是什么?
Vaishalee P Kenkre,Brad S Kahl
Vaishalee P Kenkre
Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with symptomatic or asymptomatic disease and with high or low tumor burden. Decisions to treat in the frontline are made based on histology, pr...
From the guest editor: pressing questions in the care of patients with lymphomas [0.03%]
本期客座编辑导语:淋巴瘤患者的治疗面临的重要问题
James O Armitage
James O Armitage
Michele Gabree,Meredith Seidel
Michele Gabree
Many hereditary cancer predisposition syndromes are associated with cutaneous findings, both benign and malignant. Dermatological examination and histopathology, when combined with a thorough personal and family medical history, play an imp...
Robert Pilarski,Rebecca Nagy
Robert Pilarski
Numerous hereditary syndromes, caused by mutations in multiple tumor suppressor genes and oncogenes, can cause tumors in organs of the endocrine system. The primary syndromes (and genes) addressed here include multiple endocrine neoplasia t...
Nicki Chun,James M Ford
Nicki Chun
Gastric cancer is a global public health concern, ranking as the fourth leading cause of cancer mortality, with a 5-year survival of only 20%. Approximately 10% of gastric cancers appear to have a familial predisposition, and about half of ...